...
 Why us?  Why us? please click dropdown
4.8/5 out of 3,500+ reviews
Regulated: CQC Registered | 1-5796078466
  • Verified Content: Approved by the Women’s Health Clinic Clinical Team.
  • Educational Use: This is not a substitute for professional medical advice, diagnosis, or treatment.
  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • MEDICAL EMERGENCY:

    If you need urgent help, use NHS 111. For a life-threatening emergency, call 999.

 Author  Find more about the author
Dr Farzana Khan

Dr Farzana Khan

Verified

Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in dermatology and obstetrics & gynaecology across the North of England and completed her MRCGP (CCT, 2013) and the Diploma of the Faculty of Sexual & Reproductive Health (2013). Her clinical focus is vaginal health—including dryness/GSM, sexual function concerns, lichen sclerosus, and comfort or volume changes. She offers careful assessment, discusses medical and conservative options first, and considers selected regenerative or aesthetic treatments where appropriate. Dr Farzana also trains clinicians as a KOL/Trainer with Neauvia, Asclepion Laser, and RegenLab (since 2023). Ongoing CPD includes IMCAS, CCR, ACE and expert training in women’s intimate fillers, PRP, and polynucleotide injectables. Her approach is simple: clear explanations, realistic expectations, and shared decision-making. Authored and medically reviewed by Dr Farzana Khan.

MD MRCGP DFFP
Was this answer helpful?
Rate Dr Farzana's explanation
Medical Insight: Women's Intimate Health

Vaginal Atrophy (GSM) Solutions Doctor-Led, Evidence-Informed

Quick Answer: GSM causes dryness, pain, and urinary issues due to low oestrogen. We offer evidence-informed care ranging from NICE-recommended vaginal oestrogen to regenerative options like Laser, PRP, and HA for selected cases.

For many women, it isn't "just dryness." It can affect the bladder and urethra, leading to urinary urgency or recurrent UTIs alongside intimate discomfort. We don't use a one-size-fits-all approach; we start with a clinical assessment to understand your specific symptoms.

Why Women Choose Our Clinic

CQC-Regulated GP-Led Care Evidence-Informed

Practitioner-Led Care

Treatments by Dr Farzana Khan.

Medical Oversight

Governance by Dr Kamaljit Singh.

Treatment at a Glance

Condition

Vaginal Atrophy / GSM

Methods

Laser, PRP, HA, or Estrogen

Downtime

Minimal / Protocol Dependent

Recovery

Often immediate return to routine

Evidence-Informed

Transparent Governance

Clinical consultation for GSM with doctor
Comprehensive Care

Personalised Assessment with Our GP-Led Team

Every journey begins with understanding. We start with a clinical assessment to understand your specific pattern of symptoms, medical history, and treatment goals before discussing options.

What? - Vaginal Atrophy (GSM)

What is Genitourinary Syndrome of Menopause?

Formally termed GSM, this condition describes a collection of symptoms affecting the vulva, vagina, bladder and urethra due to declining oestrogen levels. It is not just "dryness"—it is a medical condition involving tissue changes.

The Symptoms

Daily Impact

Persistent discomfort that doesn't improve with standard lubricants and can involve urinary issues.

  • Soreness, burning, or stinging
  • Discomfort/Pain with intimacy
  • Recurrent UTIs or Urgency

Tissue Changes

Medical Picture

Low oestrogen causes the vaginal lining to become thinner, less elastic, and produce less natural moisture.

  • Epithelial thinning & fragility
  • Loss of collagen & elastin
  • pH rises (loss of protection)

Quality of Life

Emotional Cost

From relationship strain to anxiety about urinary leaks, the impact extends far beyond physical discomfort.

*GSM is typically progressive without treatment.

Causes & Prevalence: A Progressive Condition

The Driver: Oestrogen decline reduces tissue elasticity and moisture. This isn't limited to natural menopause; surgical removal of ovaries, breastfeeding, or cancer treatments can trigger sudden onset.

The Scale: Studies suggest up to 50-70% of women experience symptoms. Crucially, unlike hot flushes which often settle, vaginal atrophy is typically progressive and worsens over time without intervention.

Menopause Surgical Menopause Cancer Treatment Breastfeeding

Medical Note: Early intervention often means better outcomes and preventing progression to more severe symptoms.

Who? Ideal Candidates

Who Can Benefit From Treatment?

You might benefit from assessment if you experience persistent dryness, burning, or pain that affects your daily life. This includes women across various life stages, not just natural menopause.

Menopause & Perimenopause

The most common pathway to GSM as natural oestrogen production declines, causing tissue thinning.

Post-Partum Mothers

Breastfeeding creates a temporary low-oestrogen state that can cause symptoms similar to menopause.

Surgical Menopause

Hysterectomy with ovarian removal causes immediate oestrogen loss, often with more severe symptoms.

Cancer Survivors

Breast or ovarian cancer treatments may limit hormone options, making non-hormonal support vital.

Medication Users

Women on anti-oestrogen therapies (Tamoxifen, etc.) or treatments for endometriosis.

Recurrent UTIs

Urogenital atrophy often presents as frequent urinary infections or urgency.

Tissue regeneration concept

It's More Than Just Dryness

GSM can involve surface discomfort, tissue fragility, and urogenital changes like urgency or recurrent UTIs. That is why some women need a step-up plan rather than a single product.

Discuss Your Symptoms
Why? Our Approach

Symptom Relief vs. Tissue Regeneration

Lubricants may help with friction during sex, but they don't address underlying tissue quality, pH balance, or urinary symptoms. We focus on restoring health.

Treating vs. Masking Symptoms
Symptom relief approaches (lubricants, moisturisers) provide immediate comfort. Tissue regeneration approaches (Laser, PRP, HA) aim to stimulate collagen, elastin and blood vessel formation for structural improvement.
The Progression Without Treatment
Unlike hot flushes that often improve spontaneously, GSM is typically progressive. Without intervention, tissues continue to thin and dryness increases. Early intervention prevents progression to severe symptoms.
NICE Guidance & Laser Transparency
NICE recommends vaginal oestrogen as established care. For Laser, NICE IPG697 states long-term evidence is inadequate, so it should only be used in research. We reflect this transparency in our counselling and governance.

Evidence-Based

Transparent Care

Evidence-Informed Choice

We discuss what's established in national guidance (vaginal oestrogen) versus what's promising but emerging (PRP, Laser), so you can make decisions with full awareness.

Non-Hormonal Options

For women who cannot or prefer not to use hormonal treatments, we offer biologic and regenerative pathways like PRP and Hyaluronic Acid therapy.

Regenerative Focus

Our regenerative treatments aim to stimulate fibroblasts, increase blood vessel formation, and promote tissue remodelling rather than just masking symptoms.

Holistic Assessment

We consider your full history—including medications, lifestyle, and pelvic health—to create a plan that fits your specific physiology and recovery goals.

Evidence-Based Results

While self-care measures like moisturisers help, established atrophy often requires medical treatment. Delayed treatment allows atrophy to progress, making it harder to treat later.

Start Your Journey
Clinical Results
Price? Transparent pricing

Pricing for Vaginal Atrophy Treatments

Prices are for treatment only. A consultation and clinical assessment are required to confirm suitability and the best option for you.
Most Popular

Vaginal Laser Course

Fractional CO₂ laser for vaginal atrophy — structured as a course (suitability assessed at consultation).

£599 / £799
per
session
  • Doctor led: Laser £799 per session £1,800 for 3
    Nurse led: Laser £599 per session or £1,200 for 3
  • Clinician-led assessment, clear counselling and written aftercare
  • Course-based approach with optional maintenance if needed (results vary)
  • Can be combined with PRP/boosters for a personalised plan where appropriate
Book Free Consultation

Menu (single sessions & add-ons)

PRP (Platelet-Rich Plasma) HA
Course of 3 £2,985
£1,110
HA Hydration Booster
Course of 2 £1,400
£795
RF
Course of 4 £2,300
£699
Labia majora filler (2ml) £1,200
Exosomes
Course of 3 £2,450
£895

Vulval skin tightening £699 Final recommendations and any combination plans are confirmed after assessment.

Popular Package

Intimate Makeover

Combination package including 2* PRP, HA skin booster, and 2 laser sessions — tailored after consultation (treatment mix may vary by suitability).

Unsure Which Option is Right For You?

You don't need to decide alone. Our GP-led team offers a comprehensive medical assessment to review your symptoms and recommend the safest plan.

Book Medical Assessment
Consultation
Risks? Safety & Eligibility

Concern and Safety – Contraindications

We adhere to a universal "pause and assess first" policy to ensure your safety and suitability for treatment.

Absolute Contraindications

We won't proceed with any GSM treatment if you have:

  • Undiagnosed Bleeding: Especially post-menopausal bleeding, which requires investigation first.
  • Active Infection: Bacterial vaginosis, thrush, STIs, or PID.
  • Suspected Malignancy: Until appropriate cancer investigation and clearance is obtained.
  • Pregnancy: Assessment welcome, but treatment is deferred to the post-partum period.

Requires Discussion

Specific treatments may need careful review if you have:

Radiotherapy History of pelvic radiotherapy alters tissue response (Laser caution).
Clotting Disorders PRP is not suitable if you have low platelets or blood disorders.
Exosome Status Discussed as investigational with clear regulatory context.
Cancer History Requires oncology input, especially for hormone-sensitive cases.

Confidential Medical Review

Most conditions do not rule out treatment but may change the choice of technology used. We can liaise with your oncology team or specialist to ensure appropriate care.

Disclaimer: This list is not exhaustive. A full medical history is taken during your consultation. Information provided on this site is for educational purposes and does not constitute medical advice.

Unsure Which Option is Right For You?

Clinical Image

You don't need to decide alone. Our GP-led team offers a comprehensive medical assessment to review your symptoms and recommend the safest plan.

Common Questions

Treatment FAQs

Everything you need to know about the procedure and recovery.

Is vaginal atrophy the same as vaginal dryness?
Dryness is a symptom, but GSM is broader. True vaginal atrophy involves tissue thinning, loss of elasticity, pH changes and sometimes urinary symptoms too. Simple dryness might respond to moisturisers, but established atrophy usually needs comprehensive treatment.
Do urinary symptoms (urgency/UTIs) really link to GSM?
Yes, they genuinely can. The urethra and bladder base are oestrogen-sensitive tissues. When oestrogen drops, these structures can become thinner and more vulnerable. NICE specifically notes urinary symptoms including urgency and recurrent UTIs can occur with urogenital atrophy.
What's the most established treatment in UK guidance?
NICE recommends offering vaginal oestrogen for menopausal genitourinary symptoms. It has decades of safety and efficacy data and remains first-line treatment. We discuss this option alongside regenerative treatments.
Is laser "proven" for GSM?
No, not in the way vaginal oestrogen is proven. NICE states that long-term safety and efficacy evidence is inadequate and it should be used only in research. We are transparent about this evidence gap and ensure you understand laser is not a first-line established treatment.
Can I choose a non-hormonal plan?
Often yes. Options include non-hormonal moisturisers, lubricants, HA therapies, PRP and laser. We'll explain the pros and cons of hormonal versus non-hormonal options so you can decide with clarity.
Will vaginal oestrogen cause systemic hormonal effects?
Vaginal oestrogen is designed to work locally. Studies show blood oestrogen levels stay within postmenopausal range for most women. It is often suitable even for women who can't use oral HRT, though specific cancer histories need individual assessment.
How quickly will I see improvement?
It varies. Vaginal oestrogen typically shows improvement within 2-3 weeks but builds over 2-3 months. Laser protocols suggest improvement building across the three-session course. We set realistic expectations during consultation.
Is GSM treatment permanent or will I need ongoing maintenance?
Vaginal atrophy is a chronic condition reflecting ongoing low oestrogen, so most treatments require maintenance. Vaginal oestrogen is usually continued long-term. Regenerative treatments often need annual maintenance sessions.
Can I combine treatments?
Sometimes yes. For example, vaginal oestrogen can be combined with PRP or HA for women seeking both hormonal tissue support and regenerative enhancement. We'll advise on combinations that are safe for you.
I had breast cancer – can I have any of these treatments?
It depends on your specific cancer type and status. Some women after breast cancer can use vaginal oestrogen under oncology guidance. Non-hormonal options like laser, PRP or HA might be suitable for others. We recommend discussion with your oncology team.
What if I've tried vaginal oestrogen and it hasn't worked?
First, we'd review dosing, duration, and technique. If vaginal oestrogen has been tried adequately without sufficient improvement, regenerative options like laser, PRP or HA might offer additional benefit.
Are there any long-term risks with these treatments?
For vaginal oestrogen, long-term safety is well-established. For regenerative treatments (laser, PRP), long-term risks are less certain; potential concerns include tissue scarring if overused. They currently lack the multi-decade clinical data of hormonal therapies.

Have a specific question?

Our medical team is happy to discuss your specific concerns in a private setting.

Ask a Medical Professional
Self-Care & Myths

Lifestyle Support & Common Myths

Method 1: Transvaginal Laser (Mechanism & Protocol)

The Mechanism: The laser delivers controlled thermal energy to the vaginal lining. This micro-injury intends to stimulate fibroblasts (collagen-producing cells) and increase blood vessel formation (neovascularisation), promoting tissue remodelling[cite: 207].

The Protocol: Most protocols involve 3 sessions spaced 4–6 weeks apart. A small probe delivers 360-degree treatment, typically taking 5-15 minutes with no anaesthesia required [cite: 205, 208-209].

Clinical Note: As per NICE IPG697, we use this only in a research-governed context due to the need for more long-term efficacy data[cite: 213].

Method 2: PRP (Platelet-Rich Plasma) Science

Biological Theory: We concentrate your own blood's platelets, which contain growth factors like PDGF and VEGF. When injected, these are thought to attract stem cells and trigger natural tissue regeneration and blood flow improvements [cite: 220-221].

Evidence Status: PRP is an emerging biologic option. Pilot studies report improvements in the Vaginal Health Index and dyspareunia, but large-scale long-term trials are still developing[cite: 223].

Method 3: Hyaluronic Acid (Deep Hydration)

How it works: Hyaluronic acid (HA) is a naturally occurring molecule that holds up to 1,000 times its weight in water. Unlike surface moisturisers, injectable HA is placed within tissue layers to provide deep cushioning, hydration, and support for elasticity [cite: 226-228].

Best For: Women seeking immediate non-hormonal hydration or those with contraindications to oestrogen[cite: 235].

Method 4: Exosomes (Investigational)

The Concept: Exosomes are cellular "messaging packages" containing proteins and signalling molecules that facilitate cell-to-cell communication. They are theorised to deliver regenerative signals that modulate inflammation and promote healing [cite: 236-238].

Regulatory Status: This is strictly an investigational treatment. We only discuss this where there is a clear clinical rationale, with full transparency about the lack of long-term data and current UK regulatory considerations [cite: 240-243].

Daily Habits That Help

Regular use of vaginal moisturisers (2-3 times weekly, not just before sex) helps maintain baseline hydration. Use water-based lubricants during intimacy to reduce friction. Avoid perfumed products, harsh soaps, douching, or tight synthetic clothing. Staying hydrated and maintaining regular sexual activity (where comfortable) also supports tissue elasticity ("use it or lose it" principle).

Common Myths Debunked
  • "It's just part of ageing": False. Symptoms are treatable, not something you must endure.
  • "Only old women get it": False. It affects younger women after surgical menopause, breastfeeding, or cancer treatment.
  • "Lubricant solves the problem": False. Lubricants reduce friction but don't fix underlying tissue thinning or pH changes.
  • "It means you're not aroused": False. Arousal is different from tissue health; even aroused tissues can remain dry and fragile.
Impact on Daily Life

The burden is often hidden. Pain during sex can cause relationship strain and anxiety. Persistent burning or urinary urgency can interfere with work, exercise, and social confidence. Many women delay seeking help due to embarrassment, but your symptoms are real, valid, and treatable.

Clinical References & Citations
  • 1. NICE IPG697: Transvaginal laser therapy for urogenital atrophy. View Guidance
  • 2. NICE NG23: Menopause: identification and management. View Guidance
  • 3. NICE IPG697: Recommendations. View Guidance
  • 4. FDA Warns Against Use of Energy-Based Devices. View Communication
  • 5. PubMed: Role of Platelet-Rich Plasma in Genitourinary Syndrome. View Study
  • 6. PMC: Navigating the Global Regulatory Landscape for Exosomes. View Article
  • 7. WSH NHS: Atrophic vaginitis genitourinary syndrome of the menopause. View Leaflet
  • 8. British Menopause Society: Genitourinary Syndrome of Menopause (GSM). View Statement
  • 9. PMC: A randomized, pilot trial comparing vaginal hyaluronic acid. View Study